Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04713111 · ClinicalTrials.gov registry record · NA
Stress and Recovery in Frontline COVID-19 Workers
A NA study, sponsored by 4YouandMe.
- Completed
- Registry status
- NA
- Development phase
- 383
- Enrollment target
NCT04713111: Completed NA study, sponsored by 4YouandMe.
NCT04713111 is a NA study that has completed, run by 4YouandMe. The registered enrollment target is 383 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04713111, a NA study, has completed, sponsored by 4YouandMe.
- COMPLETED
- Registry status
- NA
- Development phase
- 383 participants
- Enrollment target
Study Summary
The novel coronavirus (COVID-19) pandemic has caused an unprecedented stress on healthcare systems in affected countries, and in particular, on the healthcare workers at the frontline working directly with COVID-19 positive patients. Numerous lines of evidence support the damaging impact of stress on our immune systems which increases susceptibility to infection. Yet, the accurate measurement of immediate stress responses in real time and in naturalistic settings has so far been a challenge, limiting our understanding of how different facets of acute or sustained stress increases susceptibility. This study utilizes wearable technologies including an Oura smart ring as well as semi-continuous passive and active biometric measurements carried out using individuals' own smartphones equipped with applications to track and transmit key data to measure frontline workers stress and recovery during a uniquely stressful and high-risk work environment.
Primary Outcome
Proportion of participants completing the study
Interventions
- BEHAVIORAL Lifestyle (Meditation)
- BEHAVIORAL Lifestyle (Exercise)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2020-05-04 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
What the finished NCT04713111 record still lists
NCT04713111 is an interventional study that assigns participants to a tested intervention. The registered 383 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Lifestyle (Meditation) is the first listed.
NCT04713111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04713111 about?
NCT04713111 is a clinical study titled "Stress and Recovery in Frontline COVID-19 Workers". The novel coronavirus (COVID-19) pandemic has caused an unprecedented stress on healthcare systems in affected countries, and in particular, on the healthcare workers at the frontline working directly with COVID-19 positive patients. Numerous lines of evidence support the damaging impact of stress o...
What is the current status of trial NCT04713111?
This trial is currently completed. It is a NA study. The enrollment target is 383 participants. The study started on 2020-05-04. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT04713111?
The interventions under investigation include: Lifestyle (Meditation) (BEHAVIORAL), Lifestyle (Exercise) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04713111?
This trial is sponsored by 4YouandMe, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04713111's enrollment target sits among peer trials
383 273rd of 2000 higher than 1,728 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06056830 · 383 participants · Phase 3
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- NCT06277661 · 384 participants · NA
The Mom and Infant Outcomes (MOMI) Study
- NCT06372964 · 384 participants · Phase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- NCT06501040 · 384 participants · NA
Increasing Knowledge and Interest in Cancer Clinical Trials
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI